US Bancorp DE lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 91,342 shares of the company’s stock after selling 1,186 shares during the period. US Bancorp DE owned about 0.06% of Henry Schein worth $7,768,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. NEXT Financial Group Inc acquired a new stake in Henry Schein during the 3rd quarter worth about $103,000. McAdam LLC acquired a new stake in Henry Schein during the 3rd quarter worth about $104,000. Squar Milner Financial Services LLC acquired a new stake in Henry Schein during the 2nd quarter worth about $120,000. Piedmont Investment Advisors LLC acquired a new stake in Henry Schein during the 2nd quarter worth about $130,000. Finally, Fuller & Thaler Asset Management Inc. raised its holdings in Henry Schein by 57.1% during the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after buying an additional 800 shares during the period.
Several research firms have issued reports on HSIC. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $98.00 target price on the stock in a research note on Friday, October 5th. Barrington Research lifted their target price on Henry Schein from $92.00 to $96.00 and gave the company an “outperform” rating in a research note on Thursday. ValuEngine raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Saturday, October 6th. BidaskClub raised Henry Schein from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 6th. Finally, Morgan Stanley lifted their target price on Henry Schein from $65.00 to $66.00 and gave the company an “underweight” rating in a research note on Tuesday, October 9th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $84.41.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.02. The business had revenue of $3.28 billion during the quarter, compared to analysts’ expectations of $3.37 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The firm’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.87 EPS. As a group, equities analysts forecast that Henry Schein, Inc. will post 4.12 earnings per share for the current year.
WARNING: This article was first posted by Community Financial News and is owned by of Community Financial News. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://www.com-unik.info/2018/11/10/henry-schein-inc-hsic-holdings-cut-by-us-bancorp-de.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: The risks of owning bonds
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.